Norman Birenbaum

The cannabis sector is excited for several major catalysts that could help provide momentum after setbacks. Alongside the SAFER Banking Act in the Senate that could help provide financing to cannabis sectors, the potential reclassification of marijuana as a Schedule 1 substance could create...

The U.S. Food and Drug Administration has not given up on regulating CBD and hemp-derived products in a way that would be safe for consumers and producers. Last week, the administration held a virtual panel “A New Way Forward for Cannabidiol and Other Hemp Products” for ...

The Food and Drug Administration (FDA) announced in January it will not regulate CBD as a food and dietary supplement ingredient and that it plans to work with Congress to create "safeguards and oversight to manage and minimize risks related to CBD products." While this announcement...

After years of struggling with regulations on marijuana-based products, the Food and Drug Administration (FDA) is signaling that it has found a way to approach the issue. The research on whether legal cannabis is safe in food or supplements is already underway, reported the Wall Street Journal...

FDA Names Ex-NY Cannabis Policy Regulator As Advisor On Cannabis Research The FDA has named Norman Birenbaum to serve as its senior public health advisor on cannabis research and regulatory actions, reported Inside Health Policy. This is the first time the FDA has hired a cannabis research and...

The FDA has appointed Norman Birenbaum to be the its senior public health advisor on cannabis research and regulatory actions, reported Inside Health Policy. Why This Matters This is the first time the FDA has hired a cannabis research and...